Improving Driving in Young People With Autism Spectrum Disorders

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This study will examine the effects of treatment with the anti‐anxiety medicine buspirone on driving performance (eye tracking) in individuals with high‐functioning autism spectrum disorder (HF‐ASD). The study consists of an Assessment Visit at Massachusetts General Hospital (MGH), as well as two Driving Simulation visits that will take place at Massachusetts Institute of Technology (MIT). Subjects will be given buspirone and asked to take the medication for the two days preceding the Driving Simulation Visit.
Epistemonikos ID: 75cbc317c4a7c8788aef1cfd6b9084e538154527
First added on: May 21, 2024